Daniel R. Kaul

IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 23, 2026

IDSA 2025 Guideline on the Use of Vaccines for the Prevention of Seasonal Influenza Infections in Immunocompromised Patients.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 23, 2026

A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: August 24, 2025

A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: August 24, 2025

Don't Test Twice, It's All Right.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: April 16, 2025

Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: November 18, 2023

American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.

Journal: Transplantation and cellular therapy

Published: September 23, 2023

An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 30, 2023

Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series.

Journal: Open forum infectious diseases

Published: February 14, 2023

Cytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 01, 2023

IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients.

IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients.

IDSA 2025 Guideline on the Use of Vaccines for the Prevention of Seasonal Influenza Infections in Immunocompromised Patients.

IDSA 2025 Guideline on the Use of Vaccines for the Prevention of Seasonal Influenza Infections in Immunocompromised Patients.

A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.

A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.

A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients.

A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients.

Don't Test Twice, It's All Right.

Don't Test Twice, It's All Right.

Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study.

Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study.

American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.

American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.

An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections.

An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections.

A New Antiviral Option for Cytomegalovirus Prevention After Kidney Transplant.

A New Antiviral Option for Cytomegalovirus Prevention After Kidney Transplant.

Risk of Staphylococcus aureus Bacteremia Before and After Solid Organ Transplantation.

Risk of Staphylococcus aureus Bacteremia Before and After Solid Organ Transplantation.

Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series.

Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series.

Cytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation.

Cytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation.